Radius Announces Positive Phase 3 Topline Results for TYMLOS® (a

RDUS: Radius Health Inc.
2021-10-18 08:30:00
Radius Announces Positive Phase 3 Topline Results for TYMLOS® (abaloparatide) Subcutaneous Injection in Males with Osteoporosis
Beyond Technical Analysis

Aviso legal